Significance of cyclooxygenase‑2, prostaglandin E2 and CD133 levels in sunitinib‑resistant renal cell carcinomaLei Luo(Fujian Medical University), Lijiang Sun(Qingdao University)Oncology LettersJune 6, 201910.3892/ol.2019.10442Cited by 15SaveCiteExport RISWatch citationsRelated PapersThe influence of genetic variants of sorafenib on clinical outcomes and toxic effects in patients with advanced renal cell carcinoma|Scientific Reports|2016|31Obesity is a predictor in prostate cancer patients receiving prostatectomy after neoadjuvant hormonal therapy|Tumori Journal|2019|2